Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Longitudinal Assessment of Cognitive Impairment in Multiple Sclerosis with Advanced Brain Magnetic Resonance Imaging Measures of Myelin

FY 2022-23

Summary
Multiple sclerosis (MS) is a prevalent neurological disease involving myelin damage in the brain and spinal cord. Up to 70% of people with MS (pwMS) are affected by cognitive impairments (CI). Myelin water imaging (MWI) is a magnetic resonance imaging (MRI) technique that can detect changes in apparently normal brain tissue (normal appearing white matter; NAWM). Cross sectional studies have shown that increased myelin damage, recorded as a high myelin heterogeneity index (MHI), is associated with worse CI. However, the long-term relationship between MHI and CI is unknown. The objective of this study is to determine whether baseline MHI in NAWM can predict long term cognitive performance. Cognitive reserve represents the brain’s capacity to withstand a level of damage prior to CI presentation. It is possible that a low baseline MHI may represent pwMS who have small cognitive reserves and thus are at high risk for increased cognitive decline. It is hypothesized that high MHI at baseline will be associated with worse long-term CI. Baseline data for this single-centre study has been completed, and year-4 data collection is underway. Brain MRIs for pwMS and healthy controls will be used to calculate MHI. Participants will complete several clinical assessments to evaluate CI. These include the Symbol Digit Modalities Test, the Controlled Oral Word Association Test, the Selective Reminding Test, and the Brief Visuospatial Memory Test Revised. The data will be used to assess the relationship between baseline MHI in NAWM and year 4 CI. This study has the potential to provide a biomarker for CI, which can help to identify patients who are at high risk of cognitive decline and improve the efficiency of future clinical studies.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486297
Name
Kalau Olivia M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Longitudinal Assessment of Cognitive Impairment in Multiple Sclerosis with Advanced Brain Magnetic Resonance Imaging Measures of Myelin
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker; Cognitive Impairments; Longitudinal; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin; Myelin Water Imaging
Abstract
Multiple sclerosis (MS) is a prevalent neurological disease involving myelin damage in the brain and spinal cord. Up to 70% of people with MS (pwMS) are affected by cognitive impairments (CI). Myelin water imaging (MWI) is a magnetic resonance imaging (MRI) technique that can detect changes in apparently normal brain tissue (normal appearing white matter; NAWM). Cross sectional studies have shown that increased myelin damage, recorded as a high myelin heterogeneity index (MHI), is associated with worse CI. However, the long-term relationship between MHI and CI is unknown. The objective of this study is to determine whether baseline MHI in NAWM can predict long term cognitive performance. Cognitive reserve represents the brain’s capacity to withstand a level of damage prior to CI presentation. It is possible that a low baseline MHI may represent pwMS who have small cognitive reserves and thus are at high risk for increased cognitive decline. It is hypothesized that high MHI at baseline will be associated with worse long-term CI. Baseline data for this single-centre study has been completed, and year-4 data collection is underway. Brain MRIs for pwMS and healthy controls will be used to calculate MHI. Participants will complete several clinical assessments to evaluate CI. These include the Symbol Digit Modalities Test, the Controlled Oral Word Association Test, the Selective Reminding Test, and the Brief Visuospatial Memory Test Revised. The data will be used to assess the relationship between baseline MHI in NAWM and year 4 CI. This study has the potential to provide a biomarker for CI, which can help to identify patients who are at high risk of cognitive decline and improve the efficiency of future clinical studies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kalau, Olivia M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~